Home > News > Nanogen Launches Cystic Fibrosis Analyte Specific Reagents
March 23rd, 2006
Nanogen Launches Cystic Fibrosis Analyte Specific Reagents
Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today it has expanded its molecular reagent product portfolio with analyte specific reagents (ASRs) designed to detect 23 wild type and mutation sequences associated with cystic fibrosis (CF).
Source:
prnewswire
Bookmark:
Products
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Peratech designs the QTC Ultra Sensor - an ultra-sensitive touch sensor for domestic, commercial and industrial use: Pressure sensor so sensitive that it can be operated through glass or steel sheet May 13th, 2013
Industrial Nanotech Launches Nansulate(R) Vinyl Fresh: Clear Liquid Thermal Insulation and UV Protection Coating Rejuvenates Vinyl Siding on Homes April 18th, 2013
MouthWatchers Nano-Silver Tooth Brush Released for Sale April 12th, 2013
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Announcements
Less is More: Novel Cellulose Structure Requires Fewer Enzymes to Process Biomass to Fuel June 19th, 2013
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013